Invention Grant
- Patent Title: Cytotoxic agents for the treatment of cancer
-
Application No.: US14893821Application Date: 2014-06-04
-
Publication No.: US10278981B2Publication Date: 2019-05-07
- Inventor: Daniel Levitt
- Applicant: CytRx Corporation
- Applicant Address: US CA Los Angeles
- Assignee: CYTRX CORPORATION
- Current Assignee: CYTRX CORPORATION
- Current Assignee Address: US CA Los Angeles
- Agency: Sheridan Roass P.C.
- International Application: PCT/US2014/040872 WO 20140604
- International Announcement: WO2014/197569 WO 20141211
- Main IPC: A61K31/704
- IPC: A61K31/704 ; C07H15/26 ; A61K47/54 ; A61K45/06
Abstract:
The present invention relates to a method of treating brain cancer comprising administering a therapeutically effective substance to a patient, wherein the therapeutically effective substance comprises: (I), or a pharmaceutically acceptable salt thereof, wherein X is a. moiety that can be cleaved hydrolytically or enzymatically in the body of the patient in a pH-dependent manner.
Public/Granted literature
- US20160089388A1 CYTOTOXIC AGENTS FOR THE TREATMENT OF CANCER Public/Granted day:2016-03-31
Information query
IPC分类:
